| Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
|---|
| 02/04/2010 | US20100029947 Pyridyltetrahydropyridines and Pyridylpiperidines, and Method of Manufacturing Them |
| 02/04/2010 | US20100029919 Pyrazole derivative, medicinal composition containing the same, medicinal use thereof and intermediate in producing the same |
| 02/04/2010 | US20100029754 Thiophene-carboxamide derivatives and their use as inhibitors of the enzyme ikk-2 |
| 02/04/2010 | US20100029745 Derivatives of substituted 3-phenyl-1-(phenylthienyl)propan-1-ones and of 3-phenyl-1-(phenylfuranyl) propan-1-ones, preparation and use |
| 02/04/2010 | US20100029735 Therapeutic compounds |
| 02/04/2010 | US20100029719 Arylsulfonamide derivatives as c-jun-n-terminal kinases (jnk's) inhibitors |
| 02/04/2010 | US20100029682 Novel chromene and thiochromene carboxamide derivatives, methods for preparing same and therapeutic applications of same |
| 02/04/2010 | US20100029651 Aryl-substituted heterocycles, and use thereof |
| 02/04/2010 | US20100029647 3,4,(5)-substituted tetrahydrophyridines |
| 02/04/2010 | US20100029640 Neuroprotective agents for the prevention and treatment of neurodegenerative diseases |
| 02/04/2010 | US20100029639 Ion channel modulating compounds and uses thereof |
| 02/04/2010 | US20100029607 Substituted Piperazines as CB1 Antagonists |
| 02/04/2010 | CA2732618A1 Pyrrole carboxylic acid derivatives as antibacterial agents |
| 02/04/2010 | CA2731909A1 5-alkynyl-pyrimidines |
| 02/04/2010 | CA2731323A1 Cycloalkylidene and heterocycloalkylidene histone deacetylase inhibitor compounds |
| 02/03/2010 | EP2149573A1 Substituted indole sulfonamide compounds their preparation and use as medicaments |
| 02/03/2010 | EP2149561A1 Tetrahydroisoquinolin-1-one derivative or salt thereof |
| 02/03/2010 | EP2149551A1 N-(indol-3-ylalkyl)-(hetero)arylamid derivatives as modulators of EP2 receptors |
| 02/03/2010 | EP2148868A1 Novel aromatic heterocyclic carboxylic acid amide derivatives useful as potassium channel modulators |
| 02/03/2010 | EP2148692A2 Melanocortin receptor ligands modified with hydantoin |
| 02/03/2010 | EP1778677B1 Heterocyclic condensed compounds useful as antidiuretic agents |
| 02/03/2010 | CN100586945C Substituted 1-piperidin-4-yl-4-pyrrolidin-3-yl-piperazine derivatives and their use as neurokinin antagonists |
| 02/03/2010 | CN100586927C Amide derivatives and their use as inhibitors of 11-beta-hydroxysteroid dehydrogenase |
| 02/02/2010 | US7655804 Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient |
| 02/02/2010 | US7655797 Intermediates for making 2,4-pyrimidinediamine compounds |
| 02/02/2010 | US7655675 Gamma-secretase inhibitors |
| 02/02/2010 | US7655649 Inhibitors of Akt activity |
| 02/02/2010 | US7655641 3-(4-{2-[(5-Fluoro-3- methyl-benzo[b]thiophene-2- sulfonyl)-propyl- amino]-ethylsulfanyl}- 2-methyl-phenyl)- propionic acid; peroxisome proliferator activated receptor (PPAR); syndrome X, type II diabetes, hyperglycemia, hyperlipidemia, obesity, hypertension, arteriosclerosis and cardiovascular diseases |
| 02/02/2010 | CA2541301C P-glycoprotein inhibitor, method for preparing the same and pharmaceutical composition comprising the same |
| 02/02/2010 | CA2454830C Substituted urea neuropeptide y y5 receptor antagonists |
| 02/02/2010 | CA2418868C 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists |
| 02/02/2010 | CA2401832C 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity |
| 02/02/2010 | CA2390858C N-acylpyrrolidin-2-ylalkylbenzamidine derivatives as inhibitors of factor xa |
| 02/02/2010 | CA2333963C Carboxylic acids and carboxylic acid isosteres of n-heterocyclic compounds |
| 02/02/2010 | CA2294809C Novel 2-(iminomethyl)amino-phenyl derivatives, preparation, application as medicines and compositions containing same |
| 01/28/2010 | WO2010011853A2 Beta-and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds |
| 01/28/2010 | WO2010011626A2 Pyridinyl modulators of ϒ-secretase |
| 01/28/2010 | WO2010010154A1 3,4-diarylpyrazoles as protein kinase inhibitors |
| 01/28/2010 | WO2009145357A8 Benzo [1, 4] diazepines substituted at the 1-position by a ring, for use as antidepressants |
| 01/28/2010 | WO2009101018A3 3-alkyl-piperazine derivatives and uses thereof |
| 01/28/2010 | WO2008137816A8 Tricyclic compounds as matrix metalloproteinase inhibitors |
| 01/28/2010 | US20100022773 Apoptosis promoters |
| 01/28/2010 | US20100022594 thiophene sulfonamide derivatives such as 5-Chloro-N-[(S)-2-hydroxy-1-phenylethyl]thiophene-2-sulfonamide, that inhibit the production of beta amyloid protein from amyloid precursor protein; capable of passing through the blood-brain barrier, used for treatment of Alzheimer's disease and Down's syndrome |
| 01/28/2010 | US20100022585 Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds |
| 01/28/2010 | US20100022544 Cyclically substituted 3,5-dicyano-2-thiopyridines and use thereof |
| 01/28/2010 | US20100022525 Arginine Derivatives with NP-I Antagonistic Activity |
| 01/28/2010 | US20100019229 Thiophene compound having phosphoric ester and process for producing the same |
| 01/28/2010 | CA2731869A1 Beta-and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds |
| 01/28/2010 | CA2731190A1 Pyridinyl modulators of .gamma.-secretase |
| 01/28/2010 | CA2731146A1 3,4-diarylpyrazoles as protein kinase inhibitors |
| 01/27/2010 | EP2147923A1 Method for producing aromatic compound |
| 01/27/2010 | EP2146963A2 Dual-acting antihypertensive agents |
| 01/27/2010 | EP2146957A1 Quaternary ammonium compounds useful as muscarinic receptor antagonists |
| 01/27/2010 | EP2146753A2 18f fluoro-benzoyl labelled biological active compounds as diagnostic imaging agents as well as benzotriazol-1-yloxy-benzoyl , 2,5-dioxo-pyrrolidin-1-yloxy)benzoyl and trimethylammonio-benzoyl precursers thereof |
| 01/27/2010 | EP2146715A1 Cgrp receptor antagonists with tertiary amide, sulfonamide, carbamate and urea end groups |
| 01/27/2010 | EP1656353B1 Gabanergic modulators |
| 01/27/2010 | EP1438298B1 Piperazine derivatives with ccr1 receptor antagonist activity |
| 01/27/2010 | CN100586244C Compound, charge transporting material and organic electroluminescent element |
| 01/27/2010 | CN100584841C Andrographolide derivatives and application of the same in pharmacy |
| 01/27/2010 | CN100584840C Substituted heterocyclic compounds and uses thereof |
| 01/27/2010 | CN100584830C Gabanergic modulators |
| 01/26/2010 | US7652060 Small molecule rotamase enzyme inhibitors |
| 01/26/2010 | US7652059 1-methyl-4-trifluoromethyl-1H-pyrrole-3-carboxylic acid [2-(1,3-dimethylbutyl)phenyl]amide; protecting plants against infestation by phytopathogenic microorganisms |
| 01/26/2010 | US7652054 Gastrointestinal disorders; cardiovascular disorders; dyspepsia;anticancer agents; antiulcer agents |
| 01/26/2010 | US7652021 (2S)-4,4-difluoro-1-{N-[3-(pyrimidin-2-ylamino)-1-adamantyl]glycyl}pyrrolidine-2-carbonitrile; dipeptidyl peptidase IV enzyme inhibitors; non-insulin dependent diabetes mellitus |
| 01/26/2010 | US7652020 novel hydantoin derivatives to inhibit matrix metalloproteinases (MMPs), a disintegrin and metalloproteases (ADAMs) and/or tumor necrosis factor alpha converting enzyme (TACE) and in so doing prevent the release of tumor necrosis factor alpha (TNF- alpha ); autoimmune diseases; side effect reduction |
| 01/26/2010 | US7652015 Kinase inhibitors |
| 01/26/2010 | US7652014 Substituted 6-cyclohexylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(ADP-ribose) polymerase inhibitors |
| 01/26/2010 | US7652011 Treating chronic neuropathic or inflammatory pain; [(1-methyl-1H-pyrrol-2-yl)methyl][[1-[(4-pyrazin-2-ylpiperazin-1-yl)acetyl]-4-[3-trifluoromethyl)phenyl]piperid-4-yl]methyl]amine |
| 01/26/2010 | CA2469380C Heteroaryl-substituted aminocyclohexane derivatives |
| 01/26/2010 | CA2456606C 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity |
| 01/26/2010 | CA2338854C Nitric esters and nitrate salts of specific drugs |
| 01/26/2010 | CA2299470C Eprosartan arginyl charge-neutralization-complex and a process for its production and formulation |
| 01/21/2010 | WO2010009290A1 Alpha7 nicotinic acetylcholine receptor inhibitors |
| 01/21/2010 | WO2010009166A1 Oxindolyl inhibitor compounds |
| 01/21/2010 | WO2010009139A2 Imidazolyl pyrimidine inhibitor compounds |
| 01/21/2010 | WO2010008081A1 Azo compound, azo pigment, pigment dispersion, color composition, inkjet recording ink, color composition for color filter, color filter, and method for preparing color composition for color filter |
| 01/21/2010 | WO2010007944A1 Nitrogenated bicyclic heterocyclic compound |
| 01/21/2010 | WO2010007943A1 Nitrogenated heterocyclic compound |
| 01/21/2010 | WO2010007800A1 Novel uracil compound having amide structure and salt thereof |
| 01/21/2010 | WO2010007756A1 Pyridine derivative having ttk inhibition activity |
| 01/21/2010 | WO2010007382A1 Benzazepine derivatives and their use as hstamine h3 antagonists |
| 01/21/2010 | WO2010006962A1 Derivatives of triazines and uracils, their preparation and their application in human therapeutics |
| 01/21/2010 | WO2009091764A3 Beta-lactams for the treatment of glaucoma, ocular hypertension, baldness and hair loss |
| 01/21/2010 | WO2008156092A8 Azolylmethylidenehydrazine derivative and use thereof |
| 01/21/2010 | US20100016608 Light-activated actuator element |
| 01/21/2010 | US20100016400 Azabicyclic muscarinic receptor antagonists |
| 01/21/2010 | US20100016380 TNF-alpha production inhibitors |
| 01/21/2010 | US20100016343 Alpha7 nicotinic acetylcholine receptor inhibitors |
| 01/21/2010 | US20100016308 Tetrahydroindole Derivatives for Treatment of Alzheimer's Disease |
| 01/21/2010 | US20100015717 Mass Tags for Quantitive Analysis |
| 01/21/2010 | US20100015130 Disc-1 pathway activators in the control of neurogenesis |
| 01/21/2010 | US20100015063 Benzodiazepine Derivatives and Pharmaceutical Compositions Containing Them |
| 01/21/2010 | CA2731196A1 Benzazepine derivatives and their use as hstamine h3 antagonists |
| 01/21/2010 | CA2729909A1 Imidazolyl pyrimidine inhibitor compounds |
| 01/21/2010 | CA2729606A1 Alpha7 nicotinic acetylcholine receptor inhibitors |
| 01/21/2010 | CA2728228A1 Oxindolyl inhibitor compounds |
| 01/21/2010 | CA2728095A1 Pyrazole-containing tricyclic compounds as antagonists of an ep1 receptor |
| 01/20/2010 | EP2145622A1 Quinoline and quinazoline derivatives having affinity for 5HT1-type receptors |
| 01/20/2010 | EP2144901A1 Oligothiophene derivatives |